Scholar Rock Holding (SRRK) EPS (Basic) Growth (3y) (2020 - 2026)
Scholar Rock Holding (SRRK) EPS (Basic) Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Basic) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
-27.25% |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
139.68% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
25.99% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
41.58% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
85.94% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
14.28% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Scholar Rock Holding |
5.57 Bn |
5.09 Bn |
- |
-19.20% |
| Date | Value |
|---|
| Mar 31, 2026 |
-19.20% |
| Dec 31, 2025 |
-17.70% |
| Sep 30, 2025 |
-17.84% |
| Jun 30, 2025 |
2.58% |
| Mar 31, 2025 |
-47.21% |
| Dec 31, 2024 |
14.33% |
| Sep 30, 2024 |
13.51% |
| Jun 30, 2024 |
10.61% |
| Mar 31, 2024 |
8.09% |
| Dec 31, 2023 |
14.14% |
| Sep 30, 2023 |
12.46% |
| Jun 30, 2023 |
10.24% |
| Mar 31, 2023 |
5.47% |
| Dec 31, 2022 |
-5.66% |
| Sep 30, 2022 |
0.00% |
| Jun 30, 2022 |
-30.22% |
| Mar 31, 2022 |
20.63% |
| Dec 31, 2021 |
-31.15% |
| Sep 30, 2021 |
-32.35% |
| Jun 30, 2021 |
15.45% |
